Last updated: 2026-09-09 05:11:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Niagen Bioscience, Inc. (NAGE) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $3.11, with a market capitalization of $250.83M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.87 to $10.52. This page covers its latest market performance, valuation, price trends and company information.
$250.83M | |
$3.16 | |
$14.69 | |
$2.87 | |
$3.17 | |
467.15K | |
650.08K | |
-- | |
$10.52 | |
$2.87 | |
-- | |
-- |
Niagen Bioscience, Inc. (NAGE) last closed at $3.17 as of 2026-09-08 23:31:00, unchanged from the previous close of $3.17.
During the latest regular trading session, NAGE traded between $2.87 and $14.69, with a volume of 467.15K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Niagen Bioscience, Inc. (NAGE) moved from $3.21 to $3.11, representing a decline of 3.24% ($0.10).
The stock traded between $3.07 and $3.34 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 361.87 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 3.1%
NAGE is currently trading at $3.11, placing it 3.1% of the way from its 52-week low of $2.87 to its 52-week high of $10.52. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 117 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Niagen Bioscience, Inc. (NAGE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.